The Cancer

Don't Miss

Childhood Most cancers Survivors Face Lengthy-Time period Meningioma Danger

Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...

Professional Discusses FDA Approval of Chemo-Free Possibility for EGFR-Mutated Lung Most cancers

The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...

FDA Clears Protocol Replace for Tasquinimod in Myelofibrosis Trial

Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...

Vital Information

Facts

Latest Articles

Carotuximab Combo Proves Protected for Superior Prostate Most cancers

Carotuximab plus Erleada proved secure in a metastatic castration-resistant prostate most cancers section 2 trial: © inventory.adobe.com.Carotuximab (ENV-105) was properly tolerated when mixed...

Outpatient CAR T-Cell Remedy Could Be a Secure Choice

Dr. Olalekan O. Oluwole, an attending doctor at Vanderbilt College Medical Heart who treats sufferers with high-risk leukemias and lymphomas, mentioned how CAR...

How Biomarker Testing Can Inform Metastatic Breast Most cancers Care

Conducting biomarker testing is important with the intention to make knowledgeable therapy selections for these with breast most cancers, in keeping with Dr....

How Love Helped Me Face Leukemia and Preserve Residing

Going through leukemia and uncertainty, I leaned on love and resolve to maintain dwelling daily, regardless of worry and an unknown future forward.Two...

Coping With a Uncommon Most cancers Prognosis, Like GIST

Dr. Breelyn Wilky discusses challenges that sufferers with GIST face and shares recommendation with those that really feel overwhelmed by the rarity of...

Hot Topics